A clinical trial led by Elevance Health and the University of California, Irvine, in collaboration with Apple, Inc., found that a digital asthma self-management (DASM) program significantly improved asthma symptom control in adults. The benefits were sustained over 12 months, with participants using an iPhone app integrated with Apple Watch to track metrics and log symptoms.
Among those with uncontrolled asthma at baseline, DASM users improved Asthma Control Test (ACT) scores by an average of 4.6 points, compared to 1.8 points in the control group. The study, which enrolled 901 adult participants across 41 U.S. states, demonstrated consistent benefits across insurance types and ethnicities.
Secondary outcomes included improved medication adherence, greater confidence in self-management, and reduced impact of asthma on work productivity. These findings support the continued development of digital asthma self-management programs and highlight the potential of digital health tools to reduce the asthma burden.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.